Načítá se...
Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome
BACKGROUND: Metabolic syndrome (MetS) refers to a cluster of cardiovascular risk factors including hyperglycemia, dyslipidemia, abdominal obesity and hypertension. An effective detection of MetS not only reflects the prediction risk of diabetes mellitus and cardiovascular diseases but also helps to...
Uloženo v:
| Vydáno v: | Diabetol Metab Syndr |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4232661/ https://ncbi.nlm.nih.gov/pubmed/25400701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-6-119 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|